Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "6a4cf32ff4503514c0b03999",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "tropicamide eye drops ip",
"description": "Tropicamide eye drops IP are a prescription ophthalmic solution used to dilate the pupil (mydriasis) and temporarily paralyze the eye's focusing muscles (cycloplegia) before eye examinations and certain ocular procedures. Dilation typically begins within 20–40 minutes of application and lasts around 4–6 hours, though effects can occasionally persist longer. Tropicamide is widely used by ophthalmologists and optometrists to get a clear, detailed view of the retina, optic nerve, and back of the eye — something that isn't possible through an undilated pupil. It's generally well tolerated, though temporary blurred vision and light sensitivity are expected effects rather than side effects to worry about.\nWhat Is Tropicamide Eye Drops IP?\nTropicamide eye drops IP (manufactured to Indian Pharmacopoeia standards) are an anticholinergic (antimuscarinic) ophthalmic solution, commonly available in 0.5% and 1% strengths. “IP” indicates the formulation meets the quality and purity standards set by the Indian Pharmacopoeia.\nTropicamide belongs to the same broad drug family as atropine but has a much shorter duration of action, which is precisely why it's the preferred choice for routine eye examinations — it does its job quickly and wears off within hours rather than days. It's typically administered directly by a healthcare provider in a clinical or hospital setting, rather than self-administered at home.\nHow Tropicamide Works (Mechanism of Action)\n\nMuscarinic receptor blockade — Tropicamide blocks acetylcholine from binding to muscarinic receptors in the eye's iris sphincter and ciliary muscles.\nPupil dilation (mydriasis) — With the sphincter muscle relaxed, the pupil's natural constricting reflex is blocked, allowing it to widen.\nParalysis of accommodation (cycloplegia) — The ciliary muscle, responsible for adjusting eye focus for near vision, is also relaxed, temporarily reducing the eye's ability to focus on close objects.\nClear visualization of the fundus — With the pupil fully dilated, the examining doctor can clearly view the retina, macula, optic nerve, and vitreous — structures that are otherwise obscured behind an undilated pupil.\nNatural wearing-off — As the drug is metabolized and clears from the eye tissue, muscle tone gradually returns, and the pupil returns to its normal size and reactivity.\n\nClinical Indications\nUse CaseWhy Tropicamide Is UsedDilated fundus examinationAllows a detailed view of the retina, optic nerve, and maculaPre- and post-cataract surgeryAchieves adequate pupil dilation for surgical visibility and reduces post-operative inflammation-related discomfortDiagnosis of refractive errors in childrenCycloplegic effect prevents the eye from actively focusing, giving a more accurate refraction measurementRetinal and posterior segment proceduresSupports clear visualization for laser treatments and retinal surgeryEvaluation of optic nerve or cranial nerve abnormalitiesHelps assess disc swelling, cup-to-disc ratio, and pupillary responsesAnterior uveitis management (adjunctive use)Cycloplegic effect can reduce pain and the risk of complications like posterior synechiae\nDosage Guidelines\nParameterTypical GuidanceStandard strength0.5% or 1% ophthalmic solutionTypical doseOne drop instilled into the eye(s), as directed by the examining doctorOnset of actionDilation usually begins within 20–40 minutesDuration of effectCommonly 4–6 hours; can occasionally last longer depending on individual responseAdministration techniqueTilt the head back, pull down the lower eyelid, instill the drop, then close the eye gently for 2–3 minutes without blinking; applying gentle pressure at the inner corner of the eye can help limit systemic absorptionRepeat dosingA second drop may be used after several minutes if dilation is insufficient, at the doctor's discretion\nTropicamide is typically administered by a healthcare professional in a clinical setting rather than self-instilled at home, and dosing should always follow the specific instructions of the treating doctor.\nKey Benefits\n\nProvides fast, reliable pupil dilation, enabling a thorough examination of the back of the eye\nShort duration of action (compared to atropine) means vision and eye function return to normal within hours, not days\nWell-established, widely used mydriatic with a strong long-term safety record in clinical practice\nSupports more accurate diagnosis of refractive errors in children through its cycloplegic effect\nUseful both for routine diagnostic eye exams and as part of pre-/post-surgical eye care\nAvailable in two strengths (0.5% and 1%), allowing the examining doctor to tailor the degree of dilation needed\n\nPrecautions\n\nShould only be administered by, or under the direct guidance of, a qualified eye care professional\nWear sunglasses after application, since dilated pupils let in significantly more light and cause noticeable light sensitivity\nAvoid driving or operating machinery until vision returns to normal, as focusing on nearby objects (like a dashboard or phone) will be impaired\nDo not wear contact lenses during instillation, as the preservative in some formulations can discolor soft lenses\nUse caution in patients with a history of narrow-angle glaucoma, as pupil dilation can rarely trigger a sudden, serious rise in eye pressure (angle-closure glaucoma)\nIn children, wash hands thoroughly after administration, since rare but serious anticholinergic effects (including psychosis) have been reported, particularly with higher doses or accidental ingestion\nInform the doctor of any history of heart conditions, as anticholinergic effects can occasionally affect heart rate\n\nSide Effects\nCommon side effects (expected and temporary):\n\nBlurred vision, especially for near objects\nIncreased sensitivity to light (photophobia)\nMild stinging or burning sensation on application\nTransient increase in intraocular pressure\n\nLess common side effects:\n\nDry mouth\nHeadache\nIncreased heart rate\nFlushing or mild fever\nEye surface irritation\n\nRare but serious side effects — seek immediate medical attention:\n\nSigns of an allergic reaction: hives, difficulty breathing, swelling of the face, lips, tongue, or throat\nConfusion, slurred speech, agitation, or hallucinations (rare anticholinergic toxicity, more often reported in children)\nSudden eye pain, severe headache, nausea, or vomiting (possible signs of angle-closure glaucoma)\n\nMost side effects resolve on their own as the drug wears off within a few hours; however, any signs of a serious reaction should be reported to a doctor right away.\nComparison with Alternatives\nFeatureTropicamideAtropineOnset of action20–40 minutes30–40 minutesDuration of effect4–6 hours (short-acting)Up to 1–2 weeks (long-acting)Common useRoutine diagnostic dilation, fundus examsCycloplegic refraction in select cases, anterior uveitis managementPreferred settingOutpatient eye exams, same-day proceduresCases needing prolonged cycloplegia\nTropicamide's shorter duration makes it the preferred first choice for most routine eye examinations, where rapid return to normal vision is desirable.\nKey Statistics\n[Placeholder — pending clinical/regulatory team verification. Do not publish without confirmed source citation for dilation success rates, comparative onset/duration data, or incidence rates of rare adverse effects.]\nExpert Insight\n[Placeholder — reserved for a quote from a qualified ophthalmologist or clinical reviewer. Do not publish without a verified, attributable expert quote.]\nFrequently Asked Questions\n1. What is tropicamide eye drops used for?\nTropicamide eye drops are used to dilate the pupil and temporarily relax the eye's focusing muscles, allowing an eye doctor to clearly examine the retina, optic nerve, and back of the eye during routine eye exams and certain procedures.\n2. How long does dilation last with tropicamide?\nDilation typically begins within 20–40 minutes and lasts about 4–6 hours, though this can vary slightly from person to person. Vision usually returns to normal well within the same day.\n3. What are the risks of tropicamide eye drops?\nCommon effects include temporary blurred vision and light sensitivity. Less commonly, dry mouth, headache, or a faster heartbeat can occur. Rare but serious risks include an allergic reaction or, in susceptible individuals, a sudden rise in eye pressure (angle-closure glaucoma) — these require immediate medical attention.\n4. What are the benefits of tropicamide?\nTropicamide allows for fast, reliable pupil dilation with a much shorter recovery time than older agents like atropine, enabling accurate diagnosis of retinal and optic nerve conditions while letting patients return to normal vision within hours.\nConclusion\nTropicamide eye drops IP remain one of the most widely used and trusted tools in modern eye care, offering fast-acting, short-duration pupil dilation that allows eye care professionals to thoroughly examine the structures at the back of the eye. Its short window of action compared to older cycloplegic agents like atropine makes it especially well suited for routine diagnostic exams, where patients need their vision to return to normal within the same day. While temporary blurred vision and light sensitivity are expected parts of the experience, tropicamide has a strong long-term safety record when administered appropriately by a qualified eye care professional. As with any prescription ophthalmic agent, it should only be used under medical supervision, with simple precautions like wearing sunglasses afterward and avoiding driving until vision normalizes.\n\nDisclaimer: This content is for informational purposes only and is not a substitute for professional medical advice. Tropicamide eye drops IP are a prescription medicine and should only be administered by, or under the direct guidance of, a qualified eye care professional.\nManufactured by:\nSteris Healthcare Pvt. Ltd.\nWHO-GMP & ISO Certified Pharmaceutical Manufacturer\nEmail: contact@sterispharma.com | info@sterispharma.com\nContent last reviewed: July 2026",
"price": 50.0,
"discountamount": 15.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2466,
"imageuri": "https://productimages.withfloats.com/actual/6a4cf331dd4ec8cc0aa1b9e4.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a4cf331dd4ec8cc0aa1b9e4.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-07T12:38:07.8Z",
"updatedon": "2026-07-07T12:38:07.8Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/tropicamide-eye-drops-ip/2466",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION TRACOPA 1%",
"category": "Opthalmology Range",
"tags": [
"tropicamide eye drops ip",
"tropicamide eye drops ip uses in hindi",
"tropicamide eye drops",
"tropicamide eye drops uses",
"tropicamide eye drops uses in hindi",
"tropicamide eye drops price",
"tropicamide eye drops bottle",
"tropicamide eye drops side effects",
"tropicamide eye drops brand name"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "69942f823b20a66d9dcf9458",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "fdc of indacaterol maleate and glycopyrronium bromide inhalation powder",
"description": "GLYCOPRESS INDUS™ is a modern dual bronchodilator therapy formulated with Indacaterol Maleate and Glycopyrronium Bromide, designed for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD). This advanced inhalation formulation combines two complementary mechanisms of action to deliver sustained airway relaxation, improved lung function, and enhanced breathing comfort.\n\nCOPD is a progressive respiratory condition characterized by airflow limitation, chronic inflammation, and episodes of breathlessness. Effective management requires consistent bronchodilation to keep the airways open and reduce daily symptoms. GLYCOPRESS INDUS™ addresses this need through a once-daily maintenance approach that targets airway narrowing through dual pharmacological pathways.\n\nManufactured under strict quality standards, GLYCOPRESS INDUS™ ensures reliable dosing, stability, and optimal pulmonary delivery when used with the recommended inhalation device. It is intended for regular use and not for the treatment of sudden breathing emergencies.\n\nComposition and Mechanism of Action\n\nGLYCOPRESS INDUS™ combines two long-acting bronchodilators:\n\n1. Indacaterol Maleate (Long-Acting Beta2-Agonist – LABA)\n\nIndacaterol stimulates beta2-adrenergic receptors located in the smooth muscles of the airways. Activation of these receptors causes the muscles to relax, resulting in bronchodilation. This effect:\n\nReduces airway resistance\n\nImproves airflow\n\nDecreases breathlessness\n\nSupports 24-hour bronchodilation\n\nIndacaterol is known for its rapid onset and prolonged duration of action, making it effective for once-daily therapy.\n\n2. Glycopyrronium Bromide (Long-Acting Muscarinic Antagonist – LAMA)\n\nGlycopyrronium blocks muscarinic receptors in the bronchial smooth muscles. These receptors normally respond to acetylcholine, which causes airway constriction. By inhibiting this response, glycopyrronium:\n\nPrevents bronchospasm\n\nReduces airway tightening\n\nPromotes sustained airway relaxation\n\nDual-Action Advantage\n\nThe combination of LABA and LAMA in GLYCOPRESS INDUS™ provides enhanced bronchodilation compared to either agent alone. While indacaterol actively relaxes airway muscles, glycopyrronium prevents them from tightening. This complementary action ensures comprehensive and sustained airway management.\n\nIndications and Uses\n\nGLYCOPRESS INDUS™ is indicated for:\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD)\n\nChronic bronchitis management\n\nEmphysema management\n\nLong-term airflow limitation therapy\n\nIt is important to understand that GLYCOPRESS INDUS™:\n\nIs not a rescue inhaler\n\nShould not be used for sudden acute bronchospasm\n\nIs not intended for primary asthma treatment unless prescribed by a physician\n\nPatients should always keep a short-acting bronchodilator available for emergency relief.\n\nKey Benefits of GLYCOPRESS INDUS™\n1. Once-Daily Dosing Convenience\n\nGLYCOPRESS INDUS™ is formulated for once-daily administration, improving adherence and simplifying treatment routines.\n\n2. Dual Bronchodilation for Superior Airway Control\n\nThe LABA + LAMA combination provides broader and more effective airway relaxation compared to single-agent therapy.\n\n3. Rapid Onset with Sustained Effect\n\nIndacaterol provides quick bronchodilation, while glycopyrronium maintains airway openness for up to 24 hours.\n\n4. Improved Lung Function\n\nRegular use can enhance lung performance parameters, such as improved airflow measurements and reduced air trapping.\n\n5. Reduced Breathlessness\n\nPatients may experience decreased shortness of breath during physical activities, leading to greater independence.\n\n6. Lower Frequency of COPD Exacerbations\n\nConsistent airway maintenance can help reduce the likelihood of flare-ups and hospital visits.\n\n7. Enhanced Quality of Life\n\nBetter breathing control contributes to improved sleep, increased exercise tolerance, and overall well-being.\n\nDosage and Administration\n\nGLYCOPRESS INDUS™ should be used exactly as prescribed by a healthcare professional.\n\nGeneral Administration Guidelines:\n\nUse once daily at the same time each day.\n\nInhale using the provided inhalation device.\n\nDo not swallow capsules (if capsule-based system).\n\nDo not exceed the recommended dose.\n\nFollow inhaler technique instructions carefully.\n\nProper inhalation technique is essential for effective drug delivery. Healthcare providers should demonstrate correct usage during initial prescription.\n\nPossible Side Effects\n\nWhile GLYCOPRESS INDUS™ is generally well tolerated, some individuals may experience side effects.\n\nCommon Side Effects\n\nDry mouth\n\nCough\n\nThroat irritation\n\nHeadache\n\nNasal congestion\n\nMild tremor\n\nDizziness\n\nThese symptoms are often mild and may diminish with continued use.\n\nCardiovascular Effects\n\nDue to the beta2-agonist component (indacaterol), some patients may experience:\n\nIncreased heart rate\n\nPalpitations\n\nMild fluctuations in blood pressure\n\nPatients with pre-existing heart conditions should consult their physician before starting therapy.\n\nAnticholinergic Effects (from Glycopyrronium)\n\nDifficulty urinating\n\nBlurred vision\n\nWorsening of narrow-angle glaucoma\n\nIndividuals with urinary retention or glaucoma should use caution.\n\nRare but Serious Reactions\n\nParadoxical bronchospasm (worsening breathing immediately after inhalation)\n\nSevere allergic reactions\n\nSignificant cardiac rhythm disturbances\n\nImmediate medical attention should be sought if severe reactions occur.\n\nPrecautions and Warnings\n\nBefore starting GLYCOPRESS INDUS™, inform your healthcare provider if you have:\n\nCardiovascular disease\n\nArrhythmias\n\nHypertension\n\nHyperthyroidism\n\nDiabetes\n\nSeizure disorders\n\nGlaucoma\n\nProstate enlargement\n\nKidney impairment\n\nDrug Interactions\n\nCaution is required when using:\n\nOther long-acting beta2-agonists\n\nOther anticholinergic medications\n\nBeta-blockers\n\nDiuretics\n\nCertain antidepressants (e.g., MAO inhibitors)\n\nAlways provide a complete list of medications and supplements to your healthcare provider.\n\nWho Should Use GLYCOPRESS INDUS™?\n\nGLYCOPRESS INDUS™ is ideal for:\n\nAdults with moderate to severe COPD\n\nPatients not adequately controlled on single bronchodilator therapy\n\nIndividuals seeking a once-daily maintenance inhaler\n\nPatients requiring dual bronchodilation for improved symptom control\n\nIt is not typically recommended for pediatric patients unless specifically directed by a healthcare professional.\n\nIntegrating GLYCOPRESS INDUS™ into COPD Management\n\nFor optimal results, GLYCOPRESS INDUS™ should be part of a comprehensive COPD management plan that includes:\n\nSmoking cessation\n\nPulmonary rehabilitation programs\n\nRegular physical activity\n\nBalanced nutrition\n\nScheduled medical follow-ups\n\nAdherence to therapy and routine monitoring significantly improve long-term outcomes.\n\nStorage Instructions\n\nStore at room temperature\n\nProtect from moisture and direct sunlight\n\nKeep in original packaging until use\n\nKeep out of reach of children\nConclusion\nGLYCOPRESS INDUS™ (Indacaterol Maleate + Glycopyrronium Bromide) is a powerful dual bronchodilator designed to provide sustained airway control in individuals living with chronic obstructive pulmonary disease. By combining a long-acting beta2-agonist and a long-acting muscarinic antagonist, it offers comprehensive bronchodilation through two complementary pathways.",
"price": 703.0,
"discountamount": 211.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2308,
"imageuri": "https://productimages.withfloats.com/actual/69942f8410196f5f212c916f.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69942f8410196f5f212c916f.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-02-17T09:06:10.4Z",
"updatedon": "2026-04-08T08:59:59.008Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//fdc-of-indacaterol-maleate-and-glycopyrronium-bromide-inhalation-powder/2308",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLYCOPRESS INDUS",
"category": "ASTHMARANGE",
"tags": [
"indacaterol maleate",
"fdc of indacaterol maleate uses",
"fdc of indacaterol maleate uses in hindi",
"fdc of indacaterol maleate and glycopyrronium bromide inhalation powder",
"indacaterol maleate and glycopyrronium bromide",
"indacaterol maleate glycopyrronium bromide price",
"fdc of indacaterol maleate"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6960c83f3056ad8a5a1aecba",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Cinnarizine and Domperidone Tablets ",
"description": "CLANARIZINE DOM represents an advanced pharmaceutical combination that brings together two potent therapeutic agents—Cinnarizine and Domperidone—in a single convenient tablet formulation. This innovative combination medication addresses multiple aspects of vestibular disorders, motion sickness, and associated nausea and vomiting, providing comprehensive relief for patients suffering from these debilitating conditions. Manufactured under stringent quality control standards, CLANARIZINE DOM offers a synergistic approach to managing symptoms that significantly impact quality of life and daily functioning.The combination of Cinnarizine and Domperidone in CLANARIZINE DOM is based on sound pharmacological principles. While Cinnarizine works primarily on the vestibular system to reduce dizziness and vertigo, Domperidone acts as an effective antiemetic to control nausea and vomiting. Together, these two active ingredients provide more comprehensive symptom control than either agent alone, making CLANARIZINE DOM an excellent choice for patients experiencing vestibular disturbances accompanied by gastrointestinal symptoms.This combination therapy is particularly valuable because vertigo, dizziness, and motion sickness are frequently accompanied by nausea and vomiting. Patients suffering from these conditions often find that addressing only one aspect of their symptoms provides insufficient relief. CLANARIZINE DOM's dual-action formula tackles both the underlying vestibular dysfunction and the accompanying gastrointestinal distress, offering patients a more complete therapeutic solution that improves both comfort and functional capacity.Understanding the Active IngredientsCinnarizine is a calcium channel blocker with specific antihistaminic and vestibular suppressant properties. Unlike systemic calcium channel blockers used for cardiovascular conditions, Cinnarizine selectively acts on the blood vessels in the inner ear and brain, improving blood flow to these areas. This enhanced circulation helps reduce the frequency and severity of vertigo attacks while also preventing motion sickness. Cinnarizine also possesses mild antihistaminic effects that contribute to its anti-nausea properties, though this is not its primary mechanism of action.The medication works by blocking calcium channels in the vestibular system, which helps stabilize the sensory organs responsible for balance. By reducing the excessive stimulation of the vestibular apparatus, Cinnarizine decreases the sensation of spinning or imbalance that characterizes vertigo. Additionally, its vasodilatory effects improve microcirculation in the inner ear, which can be beneficial for conditions where reduced blood flow contributes to symptoms.Domperidone is a peripheral dopamine antagonist that acts primarily as a prokinetic and antiemetic agent. Unlike some antiemetic medications that cross the blood-brain barrier and cause sedation or extrapyramidal side effects, Domperidone works predominantly in the peripheral nervous system. It blocks dopamine receptors in the chemoreceptor trigger zone (CTZ) located outside the blood-brain barrier, effectively preventing nausea and vomiting without causing significant central nervous system effects.Domperidone also enhances gastrointestinal motility by promoting coordinated contractions of the stomach and upper small intestine. This prokinetic effect helps empty the stomach more efficiently, reducing feelings of fullness, bloating, and discomfort that often accompany vestibular disorders. By accelerating gastric emptying, Domperidone also reduces the likelihood of gastroesophageal reflux, which can exacerbate nausea in some patients.The combination of these two medications in CLANARIZINE DOM creates a complementary therapeutic effect. While Cinnarizine addresses the vestibular component of dizziness and vertigo, Domperidone manages the gastrointestinal symptoms that frequently accompany these conditions. This dual approach provides more comprehensive symptom relief and improves overall treatment outcomes compared to monotherapy with either agent alone.Clinical Applications and UsesCLANARIZINE DOM is indicated for a wide range of conditions characterized by vertigo, dizziness, and associated nausea. Understanding these clinical applications helps healthcare providers select appropriate candidates for this combination therapy.Vestibular Disorders: The primary indication for CLANARIZINE DOM includes various vestibular disorders that cause vertigo and imbalance. These conditions include Ménière's disease, benign paroxysmal positional vertigo (BPPV), vestibular neuritis, and labyrinthitis. Patients with these disorders experience episodes of spinning sensation, loss of balance, and often severe nausea. CLANARIZINE DOM helps reduce the frequency and intensity of vertigo attacks while controlling the accompanying gastrointestinal symptoms.Motion Sickness: CLANARIZINE DOM is highly effective for preventing and treating motion sickness, whether related to travel by car, boat, airplane, or amusement park rides. The medication can be taken prophylactically before travel or at the onset of symptoms. The combination is particularly useful for individuals who experience severe nausea and vomiting with motion sickness, as Domperidone provides powerful antiemetic effects that complement Cinnarizine's anti-motion-sickness properties.Migraine-Associated Vertigo: Many patients with migraines experience vestibular symptoms, including dizziness, vertigo, and motion sensitivity, either during migraine attacks or as independent episodes. CLANARIZINE DOM can help manage these vestibular manifestations of migraine, reducing both the vertigo and the nausea that often accompany migraine headaches.Post-Concussion Syndrome: Following head injuries, some patients develop persistent dizziness, balance problems, and nausea as part of post-concussion syndrome. CLANARIZINE DOM may provide symptomatic relief for these patients during their recovery period, though it should be used as part of a comprehensive treatment approach that includes rest, gradual return to activities, and vestibular rehabilitation when appropriate.Cerebrovascular Insufficiency: In older adults with reduced blood flow to the brain, symptoms such as dizziness, vertigo, tinnitus (ringing in the ears), and cognitive difficulties may develop. Cinnarizine's vasodilatory properties can improve cerebral circulation, potentially reducing these symptoms. The addition of Domperidone helps manage any associated nausea.Radiation-Induced or Chemotherapy-Induced Nausea: While not a primary indication, some healthcare providers use CLANARIZINE DOM as adjunctive therapy for patients undergoing cancer treatment who experience both nausea and dizziness. Domperidone's strong antiemetic properties are particularly valuable in this context.Key Benefits of CLANARIZINE DOMThe unique combination of Cinnarizine and Domperidone in CLANARIZINE DOM offers numerous advantages that make it a preferred choice for managing vestibular disorders and associated symptoms.Comprehensive Symptom Control: The primary benefit of CLANARIZINE DOM is its ability to address multiple symptoms simultaneously. Rather than requiring patients to take separate medications for vertigo and nausea, this combination provides unified treatment in a single tablet. This comprehensive approach improves symptom control across the full spectrum of vestibular disorder manifestations, from the spinning sensation to the gastrointestinal distress that often accompanies it.Improved Patient Compliance: Taking multiple medications can be burdensome, particularly for patients who feel dizzy or nauseated. CLANARIZINE DOM simplifies the treatment regimen by combining two medications in one tablet, making it easier for patients to adhere to their prescribed therapy. Better compliance translates to better outcomes, as consistent medication use is essential for managing chronic vestibular conditions.Synergistic Therapeutic Effects: The combination of Cinnarizine and Domperidone creates synergistic effects that enhance overall efficacy. While Cinnarizine reduces vestibular stimulation and improves inner ear blood flow, Domperidone prevents nausea and promotes gastric emptying. This dual action addresses both the cause and consequences of vestibular dysfunction, providing more complete relief than either medication alone.Reduced Central Nervous System Side Effects: Because Domperidone works primarily in the peripheral nervous system rather than crossing the blood-brain barrier extensively, CLANARIZINE DOM causes less sedation and fewer cognitive effects compared to some alternative antiemetic medications. This allows patients to maintain better alertness and function during treatment, which is particularly important for those who need to continue working or performing daily activities.Enhanced Quality of Life: Vertigo and chronic dizziness significantly impair quality of life, limiting mobility, social interactions, and occupational functioning. The nausea and vomiting that accompany these conditions add another layer of disability. By effectively controlling both vestibular and gastrointestinal symptoms, CLANARIZINE DOM helps restore patients' ability to engage in normal activities, improving overall life satisfaction and functional independence.Fast Onset of Action: CLANARIZINE DOM provides relatively rapid symptom relief, with many patients experiencing improvement within 30 minutes to 2 hours after taking the medication. This quick onset is particularly valuable for acute episodes of vertigo or when taking the medication prophylactically before situations that might trigger motion sickness.Suitable for Long-Term Use: For patients with chronic vestibular disorders requiring ongoing treatment, CLANARIZINE DOM is generally safe for extended use when properly monitored by a healthcare provider. The medication maintains its effectiveness over time without significant tolerance development, making it suitable for long-term symptom management.Improved Gastric Emptying: The prokinetic effects of Domperidone benefit not only nausea but also other gastrointestinal symptoms such as early satiety, bloating, and upper abdominal discomfort. Patients with vestibular disorders often develop gastroparesis or delayed gastric emptying secondary to their condition, and Domperidone addresses this issue effectively.Vascular Benefits: Cinnarizine's ability to improve blood flow to the inner ear and brain provides additional benefits beyond symptom control. Enhanced microcirculation may support healing and recovery in conditions where vascular insufficiency contributes to vestibular dysfunction.Side Effects and Safety ConsiderationsLike all medications, CLANARIZINE DOM can cause side effects, though not everyone experiences them. Understanding potential adverse effects helps patients recognize when to seek medical attention and allows healthcare providers to monitor therapy appropriately.Common Side Effects:The most frequently reported side effect of CLANARIZINE DOM is drowsiness or sedation, occurring in approximately 10-20% of patients. This effect is primarily attributable to Cinnarizine's antihistaminic properties. Patients should avoid driving or operating machinery until they know how the medication affects them. Taking the medication at bedtime can minimize daytime drowsiness for some patients.Dry mouth is another common side effect, affecting roughly 10-15% of patients. This occurs due to anticholinergic effects and can be managed by sipping water frequently, chewing sugar-free gum, or using saliva substitutes if severe. Maintaining good oral hygiene is important to prevent dental problems associated with reduced saliva production.Mild gastrointestinal symptoms, including constipation, abdominal discomfort, or changes in bowel habits, may occur. While Domperidone promotes gastric emptying, it can occasionally alter bowel motility. These effects are usually mild and resolve with continued use or dose adjustment.",
"price": 55.0,
"discountamount": 17.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2271,
"imageuri": "https://productimages.withfloats.com/actual/6960c8410b0da405bc908e58.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6960c8410b0da405bc908e58.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-01-09T09:19:59.281Z",
"updatedon": "2026-03-12T09:24:10.244Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//cinnarizine-and-domperidone-tablets-/2271",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CLANARIZINE DOM",
"category": "NEUROLOGY RANGE",
"tags": [
"cinnarizine and domperidone tablet uses",
"what is cinnarizine & domperidone tablet used for",
"cinnarizine domperidone combination medicine benefits",
"how cinnarizine domperidone tablet works",
"cinnarizine domperidone tablet for vertigo treatment",
"cinnarizine domperidone tablet for inner ear problem",
"cinnarizine domperidone tablet for balance disorder",
"cinnarizine domperidone tablet for travel sickness",
"cinnarizine domperidone tablet for gastric nausea",
"cinnarizine & domperidone tablet price in india",
"cinnarizine domperidone tablet brand name",
"cinnarizine domperidone tablet manufacturer in india"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "690b41bfb84ade1a1a5cf07f",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Tiotropium Bromide and Formoterol Fumarate Inhaler",
"description": "Tiotropium Bromide and Formoterol Fumarate Inhaler is a combination medication designed to provide long-term relief for patients suffering from chronic respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. This inhaler combines the bronchodilator properties of tiotropium bromide with the fast-acting benefits of formoterol fumarate, ensuring both immediate and sustained relief from breathing difficulties. By improving airflow in the lungs, this inhaler significantly enhances the quality of life for individuals with obstructive airway diseases.\n\nComposition and Mechanism of Action\nThe inhaler contains two active ingredients:\n\nTiotropium Bromide – a long-acting anticholinergic agent that relaxes the muscles around the airways, preventing bronchospasm and helping to keep the airways open for an extended period.\n\nFormoterol Fumarate – a long-acting beta-2 adrenergic agonist (LABA) that quickly relaxes airway muscles, providing fast relief from shortness of breath and wheezing.\n\nTogether, these agents work synergistically. Tiotropium ensures long-term bronchodilation, while formoterol provides rapid symptom relief, making this inhaler ideal for patients who require both immediate and sustained respiratory support.\n\nUses\nThe Tiotropium Bromide and Formoterol Fumarate Inhaler is primarily used to:\n\nManage Chronic Obstructive Pulmonary Disease (COPD) – Helps reduce the frequency and severity of COPD exacerbations, improving breathing efficiency.\n\nControl Asthma Symptoms – Offers better control of persistent asthma symptoms, particularly in patients who do not respond adequately to standard inhalers.\n\nPrevent Exercise-Induced Bronchospasm – Can be used as part of a preventive regimen for patients prone to exercise-triggered breathing difficulties.\n\nEnhance Overall Lung Function – Improves airflow and oxygen exchange, contributing to better overall respiratory health.\n\nDosage and Administration\nProper usage of the inhaler is critical for maximum effectiveness. The dosage may vary based on your condition and doctor's recommendation. General guidelines include:\n\nTypically, one inhalation twice daily (morning and evening).\n\nShake the inhaler well before each use.\n\nExhale fully, place the mouthpiece in your mouth, and inhale deeply while pressing the inhaler to release the medication.\n\nHold your breath for 10 seconds after inhalation to ensure the medication reaches deep into the lungs.\n\nRinse your mouth with water after use to reduce the risk of oral infections or irritation.\n\nPatients should strictly follow their doctor’s instructions regarding dosage, frequency, and technique, as incorrect use may reduce the medication’s effectiveness.\n\nKey Benefits\n\nDual Action for Immediate and Long-Term Relief – Combines a fast-acting bronchodilator with a long-acting maintenance agent.\n\nReduces Exacerbations – Regular use can significantly lower the risk of flare-ups and hospital visits for COPD or severe asthma patients.\n\nImproves Lung Function – Enhances airflow and oxygen intake, leading to reduced shortness of breath and wheezing.\n\nConvenient Usage – A single inhaler provides both maintenance and symptom relief, reducing the need for multiple medications.\n\nEnhanced Quality of Life – Patients often experience better sleep, increased physical activity tolerance, and improved daily functioning.\n\nSide Effects\nWhile Tiotropium Bromide and Formoterol Fumarate Inhaler is generally well-tolerated, some patients may experience side effects. Common side effects include:\n\nDry mouth or throat irritation\n\nCough or hoarseness\n\nHeadache or dizziness\n\nTremors or mild palpitations\n\nSerious but rare side effects may include:\n\nSevere allergic reactions (rash, swelling, difficulty breathing)\n\nIrregular heartbeat or chest pain\n\nWorsening of respiratory symptoms\n\nPatients should immediately consult a healthcare professional if they experience severe or persistent side effects. Regular follow-up with a doctor is recommended to monitor lung function and adjust the dosage if necessary.\n\nPrecautions\n\nNot recommended for individuals with hypersensitivity to either tiotropium bromide or formoterol fumarate.\n\nShould be used cautiously in patients with cardiovascular diseases, kidney or liver problems, or thyroid disorders.\n\nAvoid sudden discontinuation without consulting your doctor, as this may worsen symptoms.\n\nAlways carry a rescue inhaler for emergency situations, as this inhaler is primarily for maintenance and not for immediate acute attacks.\n\nPrice\nThe price of Tiotropium Bromide and Formoterol Fumarate Inhaler may vary depending on the brand, pack size, and pharmacy. It is advisable to compare prices and check with local pharmacies for the most cost-effective options. Many insurance plans may cover this inhaler under prescription respiratory medications.\n\nConclusion\nTiotropium Bromide and Formoterol Fumarate Inhaler is a highly effective combination treatment for patients suffering from COPD and asthma. By providing both rapid symptom relief and long-term airway maintenance, it helps patients breathe more easily, reduces the frequency of exacerbations, and improves overall quality of life. Proper usage, adherence to prescribed dosage, and monitoring for side effects are essential for achieving the best results. For anyone managing chronic respiratory conditions, this inhaler represents a reliable and convenient treatment option under medical guidance.",
"price": 360.0,
"discountamount": 108.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2196,
"imageuri": "https://productimages.withfloats.com/actual/690b41c1d25e5639c9089541.png",
"tileimageuri": "https://productimages.withfloats.com/tile/690b41c1d25e5639c9089541.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-11-05T12:23:27.485Z",
"updatedon": "2026-03-14T08:50:22.16Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//tiotropium-bromide-and-formoterol-fumarate-inhaler/2196",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TIOTROPIN F",
"category": "ASTHMA RANGE",
"tags": [
"Tiotropium Bromide and Formoterol Fumarate Inhaler",
"Chronic Obstructive Pulmonary Disease (COPD) and asthma.",
"Chronic Obstructive Pulmonary Disease (COPD) and asthma"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666be30aa20cb42140743ca6",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "RISPERITIME PLUS ",
"description": "RISPERITIME PLUS \nRisperidone (2mg), Trihexyphenidyl (2mg)\nIntroduction:\n\nRisperitime Plus is a combination medication containing Risperidone (2mg) and Trihexyphenidyl (2mg), designed to offer comprehensive management for psychiatric disorders. This dual-action formula targets both the symptoms of mental health conditions and the side effects associated with antipsychotic treatments, providing a balanced approach to patient care.\nKey Features and Benefits:\n\nAntipsychotic Efficacy:\n\nRisperidone: As a second-generation antipsychotic, Risperidone effectively antagonizes dopamine and serotonin receptors. This action helps mitigate symptoms such as hallucinations, delusions, and disorganized thinking, common in schizophrenia and bipolar disorder.\nMood Stabilization:\n\nRisperidone also aids in stabilizing mood swings in bipolar disorder, reducing the severity of manic episodes and preventing depressive relapses. This contributes to overall emotional balance and improved quality of life.\nManagement of Side Effects:\n\nTrihexyphenidyl: An anticholinergic agent, Trihexyphenidyl is included to manage extrapyramidal symptoms (EPS) caused by antipsychotic medications. It helps alleviate symptoms such as muscle stiffness, tremors, and restlessness, which are side effects of Risperidone and other antipsychotics.\nBehavioral and Cognitive Benefits:\n\nRisperitime Plus addresses behavioral issues such as aggression, agitation, and irritability, particularly in conditions like autism spectrum disorders and dementia-related behavioral disturbances.\nIt may also offer cognitive enhancements, improving attention, executive function, and overall cognitive performance in certain patients.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Risperitime Plus is 2mg Risperidone and 2mg Trihexyphenidyl taken orally once daily. Dosage adjustments should be based on clinical response and tolerability.\nAdministration Instructions:\nSwallow the tablets whole with water, with or without food. Consistency in dosing time each day is important for maintaining therapeutic levels.\nTitration and Maintenance:\nHealthcare providers may adjust the dosage gradually to achieve optimal symptom control while minimizing side effects. Maintenance doses are personalized to each patient's needs and treatment goals.\n\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW ",
"price": 60.0,
"discountamount": 18.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"EPS",
"food",
"life",
"EMAIL",
"needs",
"water",
"dosing",
"product",
"quality",
"tablets",
"tremors",
"dopamine",
"severity",
"patients",
"delusions",
"attention",
"Titration",
"agitation",
"aggression",
"mood swings",
"Consistency",
"information",
"restlessness",
"irritability",
"Introduction",
"tolerability",
"sterispharma",
"sterisonline",
"patient care",
"side effects",
"Key Features",
"schizophrenia",
"starting dose",
"CALL/WHATSAPP",
"manic episodes",
"hallucinations",
"Initial Dosage",
"2mg Risperidone",
"treatment goals",
"RISPERITIME PLUS",
"muscle stiffness",
"bipolar disorder",
"Maintenance doses",
"clinical response",
"behavioral issues",
"balanced approach",
"Dosage adjustments",
"executive function",
"therapeutic levels",
"Cognitive Benefits",
"Mood Stabilization",
"dual-action formula",
"serotonin receptors",
"depressive relapses",
"2mg Trihexyphenidyl",
"other antipsychotics",
"Healthcare providers",
"disorganized thinking",
"anticholinergic agent",
"psychiatric disorders",
"combination medication",
"Antipsychotic Efficacy",
"cognitive enhancements",
"extrapyramidal symptoms",
"optimal symptom control",
"antipsychotic treatments",
"comprehensive management",
"mental health conditions",
"autism spectrum disorders",
"antipsychotic medications",
"overall emotional balance",
"Administration Instructions",
"overall cognitive performance",
"second-generation antipsychotic",
"dementia-related behavioral disturbances"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1892,
"imageuri": "https://productimages.withfloats.com/actual/666be30d117f82c50b0c8762.jpeg",
"tileimageuri": "https://productimages.withfloats.com/tile/666be30d117f82c50b0c8762.jpeg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-14T06:28:26.525Z",
"updatedon": "2026-03-12T11:42:56.949Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//risperitime-plus-/1892",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "RISPERITIME PLUS ",
"category": "NEUROLOGY RANGE",
"tags": [
"Trihexyphenidyl (2mg)",
"Risperidone (2mg)",
"RISPERITIME PLUS",
"",
"risdone plus side effects",
"risdone plus dosage",
"risperidone and trihexyphenidyl tablets uses in hi"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6661520ed91d281c30c74bbb",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "R/C TIOTROPIN 3D ",
"description": "R/C TIOTROPIN 3D \nCiclesonide (400mcg), Formoterol (12mcg), Tiotropium (18mcg)\nR/C TIOTROPIN 3D is a powerful combination medication designed to provide comprehensive relief for respiratory conditions. With Ciclesonide at 400mcg, Formoterol at 12mcg, and Tiotropium at 18mcg, this formulation targets multiple aspects of respiratory health. Ciclesonide, a potent corticosteroid, helps reduce inflammation in the airways, easing breathing difficulties. Formoterol, a long-acting beta agonist, works to relax the muscles around the airways, facilitating better airflow. Tiotropium, an anticholinergic agent, further opens up the air passages, making breathing smoother and more comfortable. Together, these components create a synergistic effect, providing effective relief for individuals with respiratory conditions.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: https://www.sterisonline.com/product/r-c-tiotropin-3d-133719\n\n\n\n\n\n\n\n\n",
"price": 340.0,
"discountamount": 102.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"Call",
"Email",
"18mcg",
"12mcg",
"400mcg",
"airflow",
"muscles",
"airways",
"product",
"WhatsApp",
"Formoterol",
"Tiotropium",
"components",
"information",
"Ciclesonide",
"individuals",
"formulation",
"air passages",
"sterispharma",
"inflammation",
"sterisonline",
"multiple aspects",
"R/C TIOTROPIN 3D",
"effective relief",
"synergistic effect",
"respiratory health",
"acting beta agonist",
"comprehensive relief",
"anticholinergic agent",
"potent corticosteroid",
"respiratory conditions",
"breathing difficulties",
"powerful combination medication"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1401,
"imageuri": "https://productimages.withfloats.com/actual/666152106030c166b1a88356.png",
"tileimageuri": "https://productimages.withfloats.com/tile/666152106030c166b1a88356.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-06T06:07:10.216Z",
"updatedon": "2026-03-14T08:30:24.358Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//r-c-tiotropin-3d-/1401",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "R/C TIOTROPIN 3D ",
"category": "ASTHMARANGE",
"tags": [
"R/C TIOTROPIN 3D",
"Ciclesonide (400mcg),",
"Formoterol (12mcg)",
"Tiotropium (18mcg)",
"Formoterol inhaler",
"Formoterol fumarate",
"Formoterol fumarate and budesonide inhaler",
"Formoterol side effects",
"Formoterol Easyhaler 12 mcg"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6ae5dbe40b7c3d020d7c3b40",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Combipack Of Vonoprazan Tablets 20 mg,Clarithromycin Tablets IP 500 mg & Amoxycillin Capsules IP 500",
"description": "VONOSTRUM HP KIT is a pharmaceutical combination pack containing Vonoprazan Tablets 20 mg, Clarithromycin Tablets IP 500 mg, and Amoxicillin Capsules IP 500 mg. This combination is designed for use as part of a physician-prescribed treatment regimen for Helicobacter pylori (H. pylori) infection, a type of bacterial infection associated with the stomach and gastrointestinal tract.\n\nVONOSTRUM HP KIT combines an acid-suppressing agent with two antibiotics to support H. pylori eradication therapy. The combination works through different mechanisms: Vonoprazan helps reduce stomach acid production, while Clarithromycin and Amoxicillin act against susceptible bacterial infections.\n\nWith its convenient combipack formulation, VONOSTRUM HP KIT brings three complementary medicines together in one treatment pack, helping simplify the prescribed treatment schedule.",
"price": 149.0,
"discountamount": 40.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2509,
"imageuri": "https://productimages.withfloats.com/actual/6ae5dbe783548115dde7d54d.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ae5dbe783548115dde7d54d.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-31T12:15:32.163Z",
"updatedon": "2026-10-31T12:15:32.163Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//combipack-of-vonoprazan-tablets-20-mg-clarithromycin-tablets-ip-500-mg-amoxycillin-capsules-ip-500/2509",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VONOSTRUM HP KIT",
"category": null,
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad7442bf24c5a4bbccf4b10",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin,Sitagliptin And Metformin Hydrochloride (ER) Tablets",
"description": "GLIEMPAFLOZIN 3D 25 is a combination pharmaceutical product containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This triple-combination formulation is intended for the management of type 2 diabetes mellitus in appropriate patients, as determined by a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help control blood glucose levels. Empagliflozin belongs to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin is a biguanide antidiabetic medicine. Together, these ingredients target different pathways involved in glucose regulation.\n\nGLIEMPAFLOZIN 3D 25 provides a combination of three established antidiabetic agents in a single tablet. Its suitability depends on the patient's blood glucose levels, kidney function, current diabetes treatment, medical history, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 25\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 25 mg: An SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine.\nSitagliptin 100 mg: A DPP-4 inhibitor that increases the activity of incretin hormones involved in glucose-dependent insulin release and glucagon regulation.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, administration instructions, and approved indications should be verified against the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 25\nGLIEMPAFLOZIN 3D 25 combines three antidiabetic ingredients with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: The ingredients act through different mechanisms involved in blood glucose regulation.\nExtended-release metformin: The ER formulation is designed to release metformin over an extended period.\nOral tablet dosage form: Provides oral administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered by a healthcare professional when combination therapy is appropriate.\nThe benefits of this combination depend on the patient's clinical needs and the suitability of all three ingredients.\n\nUses of GLIEMPAFLOZIN 3D 25 Tablets\nGLIEMPAFLOZIN 3D 25 is intended for the management of type 2 diabetes mellitus, subject to the product's approved indications and the prescribing healthcare professional's judgment.\n\nType 2 diabetes is a chronic metabolic condition in which the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood glucose levels. Long-term elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three medicines in GLIEMPAFLOZIN 3D 25 target different aspects of glucose regulation. A healthcare professional may consider a combination regimen when an individual's treatment goals are not adequately achieved with a simpler regimen or when the combination is otherwise clinically appropriate.\n\nThe medicine should be used alongside an individualized diabetes-management plan that may include a balanced diet, physical activity, glucose monitoring, and regular medical follow-up. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 25 Work?\nThe three active ingredients contribute to blood glucose management through distinct mechanisms.\n\n1. Empagliflozin 25 mg\nEmpagliflozin inhibits SGLT2, a protein responsible for reabsorbing much of the glucose filtered by the kidneys. By reducing glucose reabsorption, it increases glucose excretion through urine and helps lower blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. These benefits depend on the patient's condition and the applicable prescribing information and should not be assumed to apply identically to every patient.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. Increasing incretin activity helps stimulate insulin release when blood glucose is elevated and reduces glucagon secretion when appropriate. This helps regulate glucose levels, particularly after meals.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily decreases glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nBy combining these mechanisms, GLIEMPAFLOZIN 3D 25 targets several pathways involved in type 2 diabetes. Its overall effectiveness and safety depend on appropriate patient selection, dosing, and ongoing monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 25\nWhen prescribed for an appropriate patient, this combination may offer the following treatment advantages:\n\nMultiple mechanisms of action: Addresses glucose regulation through three different pharmacological pathways.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nOral combination therapy: Combines three medicines in one tablet, which may simplify a prescribed regimen compared with taking each ingredient separately.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nIndividualized treatment options: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThese potential advantages do not guarantee a particular result. Treatment effectiveness depends on adherence, diet, physical activity, individual health status, and medical supervision.\n\nDirections for Use\nGLIEMPAFLOZIN 3D 25 should be taken only as prescribed by a qualified healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or discontinue treatment without consulting your prescriber.\nAttend recommended appointments for blood glucose monitoring and kidney-function assessment.\nIf a dose is missed, follow the official patient information or ask your healthcare professional or pharmacist for advice. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 25 is a prescription medicine and is not suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important renal considerations, and the combination may be unsuitable at certain levels of kidney impairment.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients should discuss dehydration risk, low blood pressure, and fluid intake with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin can increase the risk of genital fungal infections and may be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, excessive alcohol intake, or other predisposing conditions.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nLow blood glucose: The risk of hypoglycemia may increase when this combination is used with insulin or insulin secretagogues, such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, or an upcoming medical procedure involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, unusual weakness, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 25?\nGLIEMPAFLOZIN 3D 25 brings together Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER in a triple-combination tablet designed for the management of type 2 diabetes in appropriately selected patients.\n\nFor pharmaceutical product catalogues, distributors, pharmacies, and healthcare professionals, accurate information about the composition, mechanism of action, approved indications, and safety profile supports responsible product awareness.\n\nTreatment decisions should always be based on the patient's medical assessment and the approved product information.\n\nConclusion\nGLIEMPAFLOZIN 3D 25 Tablets combine Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. This combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 25?\n\nGLIEMPAFLOZIN 3D 25 is a combination tablet containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 25 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom the combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 25 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 25 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan as recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 25 suitable for everyone with diabetes?\n\nNo. Its suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and the approved prescribing information.",
"price": 230.0,
"discountamount": 69.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2504,
"imageuri": "https://productimages.withfloats.com/actual/6ad7442d6e565c5fe6e5b7cb.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7442d6e565c5fe6e5b7cb.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:36:27.325Z",
"updatedon": "2026-10-20T10:36:27.325Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-sitagliptin-and-metformin-hydrochloride-er-tablets/2504",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 25",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6abe4471401ae1a1106d67d9",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Bisoprolol 1.25mg",
"description": "Bisoprolol 1.25mg is the smallest tablet strength of bisoprolol, a heart-selective beta-1 blocker. Doctors usually prescribe it to start treatment or to build up the dose gradually in people with high blood pressure, chronic stable heart failure, or fast heart rhythms. It suits older adults, people with mild heart failure, and anyone who reacts strongly to beta-blockers. The medicine slows the heartbeat and eases the force of each contraction, so the heart works less hard. BISOGARD 1.25 from Steris Healthcare Pvt. Ltd. comes in a strip pack of 15 tablets. It is a Schedule H medicine, so it must only be started, changed, or stopped on a doctor's advice.\n\nProduct Snapshot\n\nBrand: BISOGARD 1.25\nManufacturer/Marketer: Steris Healthcare Pvt. Ltd., a WHO-GMP and ISO-certified pharmaceutical company in India\nActive ingredient: Bisoprolol Fumarate 1.25mg\nForm: Tablet\nPack size: 15 tablets\nDrug class: Cardioselective beta-1 blocker\nLegal status: Schedule H (valid prescription required)\nAvailability: Through Steris Healthcare's authorized pharmacies and its B2B PCD franchise network across India\nWhat Is Bisoprolol 1.25mg?\n\nIf your doctor has just prescribed bisoprolol 1.25mg, you have been given the lowest dose on purpose. Bisoprolol is a cardioselective beta-1 blocker, meaning it acts mostly on receptors in the heart and has much less effect on the lungs and blood vessels. This is a major reason it is preferred over older, non-selective beta-blockers, especially for people who also have a mild breathing problem.\n\nThe 1.25mg tablet is not a “light” medicine for mild illness. It is a carefully chosen entry point. In heart failure, a weakened heart can struggle if its rate or pressure drops too quickly, so cardiologists follow a “start low, go slow” approach. Treatment begins at 1.25mg, the response is watched for one to two weeks, and the dose is raised step by step (commonly 2.5mg, 3.75mg, 5mg, 7.5mg, and up to 10mg) as the heart adapts. That is why BISOGARD 1.25 is often the first tablet a newly diagnosed heart failure patient takes.\n\nWhat Is Bisoprolol 1.25mg Used For?\n\nDoctors commonly prescribe this strength for:\n\nChronic heart failure (HFrEF): as the first step of dose titration in patients with a reduced ejection fraction, alongside ACE inhibitors/ARBs and diuretics\nHigh blood pressure: especially in older adults, people with low body weight, and those who are sensitive to blood-pressure-lowering drugs\nStable angina: to reduce the heart's oxygen demand and relieve chest discomfort\nAfter a heart attack: in selected patients, under a cardiologist's care\nHeart rate control in some arrhythmias: sometimes used off-label at a low dose to gently bring down a fast heart rate\n\nAt 1.25mg, bisoprolol is seldom meant as the long-term sole treatment for high blood pressure in an otherwise healthy adult. It is usually the first rung of a titration ladder, or a steady maintenance dose for patients who are unusually beta-blocker sensitive (older age, low body weight, or borderline low pressure or pulse).\n\nHow Does Bisoprolol Work?\n\nBisoprolol selectively blocks beta-1 adrenergic receptors, which are packed mainly into heart muscle. This leads to several effects:\n\nSlower heart rate: the heart has more time to fill and rest between beats\nGentler contractions: the heart muscle needs less oxygen and energy\nLess renin from the kidneys: this helps blood pressure fall gradually over time\nLower overall cardiac workload: a real advantage for a heart that already struggles to pump well, as in heart failure\nKey Benefits of BISOGARD 1.25\nA gentle starting dose, well suited to careful titration in frail or elderly patients\nHeart-focused action, with less effect on the lungs and peripheral blood vessels than non-selective beta-blockers\nOnce-daily dosing, which makes it easier to stay on treatment\nA guideline-recommended beta-blocker for HFrEF with well-established outcomes data [Reviewer note: insert specific outcome statistics/trial citation pending medical sign-off]\nMade by Steris Healthcare Pvt. Ltd. under WHO-GMP and ISO-certified standards\nDosage Guidance\nUsual starting dose (heart failure): 1.25mg once a day, preferably in the morning\nDose increases: typically every 1–2 weeks (2.5mg, 3.75mg, 5mg, 7.5mg, up to a maximum of 10mg daily), depending on how well you tolerate it and on your pulse and blood pressure\nHigh blood pressure (sensitive patients): 1.25mg to 5mg once daily, as set by your doctor\nHow to take it: at the same time every day, with or without food, swallowed whole with water\nIf you miss a dose: take it when you remember, unless the next dose is almost due. Never take a double dose.\nNever stop suddenly: abrupt withdrawal can cause a rebound rise in heart rate, blood pressure, or chest pain. The dose must be reduced gradually under medical supervision.\nIs It Better to Take Bisoprolol in the Morning or at Night?\n\nMost doctors advise a morning dose. Bisoprolol lowers pulse and blood pressure, and taking it early matches its action to your daytime activity. A night-time dose could add to the body's natural overnight dip in blood pressure and raise the chance of dizziness when getting up in the dark. Some people who feel tired during the day are told by their doctor to switch to the evening. Do not change your dosing time without your doctor's approval.\n\nSide Effects of Bisoprolol 1.25mg\n\nCommon side effects\n\nTiredness or fatigue\nDizziness or light-headedness, especially on standing quickly\nCold hands or feet\nSlow pulse (bradycardia)\nHeadache\nMild stomach upset (nausea, loose stools)\nDisturbed sleep\n\nSerious side effects (get medical help promptly)\n\nVery slow heartbeat or fainting\nIncreasing breathlessness or swollen legs/ankles, which may mean heart failure is worsening\nAllergic reaction: rash, swelling of the face or throat, trouble breathing\nCold, numb, or bluish fingers and toes\nWheezing or new breathing difficulty, particularly in people with asthma or COPD\nMood changes, low mood, or confusion\nWhat Are the Bad Side Effects of Bisoprolol?\n\nThe effects that need urgent attention are a dangerously slow pulse, fainting, signs of worsening heart failure (swelling, breathlessness), severe allergic reactions, and airway tightening in people with lung disease. These are uncommon at the 1.25mg dose, but anyone who notices them should seek medical help right away. [Reviewer note: specific incidence rates pending clinical/medical sign-off]\n\nSubstitutes & Comparable Beta-Blockers\nMolecule\tSelectivity\tTypical Use Case\nBisoprolol\tHighly cardioselective\tHeart failure titration, hypertension\nMetoprolol Succinate ER\tCardioselective\tHypertension, angina, heart failure\nAtenolol\tCardioselective (older agent)\tHypertension\nCarvedilol\tNon-selective with alpha-blocking action\tHeart failure (adds vasodilation)\nPropranolol\tNon-selective\tMigraine prevention, anxiety-related fast heartbeat, essential tremor\nPrecautions & Who Should Avoid Bisoprolol\nNot suitable for people with severe bradycardia, certain forms of heart block (unless a pacemaker is fitted), unstable or acutely decompensated heart failure, or severe uncontrolled asthma\nUse carefully in diabetes, because beta-blockers can hide the warning signs of low blood sugar\nTake care in peripheral vascular disease, as cold extremities or leg pain on walking may worsen\nNever stop it abruptly; always taper under a doctor's guidance\nTell your doctor about every medicine you use, especially other blood-pressure drugs, calcium channel blockers, and certain antiarrhythmics\nIn pregnancy and breastfeeding, use only if your doctor advises it after weighing benefits and risks\nIs Bisoprolol Safe for Kidneys?\n\nThe body clears bisoprolol through both the liver and the kidneys in roughly equal measure. It is generally considered safe for people with normal or mildly reduced kidney function. When kidney impairment is significant, drug levels in the blood can rise, so your doctor may lower the dose or monitor you more closely. Always tell your prescriber about any kidney disease before starting.\n\nIs Bisoprolol a High-Risk Medication?\n\nBisoprolol is not a narrow therapeutic index drug like tacrolimus or warfarin, where small dose differences matter greatly. Even so, it needs supervised use because it directly affects heart rate and blood pressure. The main dangers are stopping it suddenly, which can set off rebound cardiac events, and using it with certain existing rhythm disorders. Taken as prescribed and checked regularly, it has a long and reassuring safety record.\n\nDoes 1.25mg Bisoprolol Lower Blood Pressure?\n\nYes. Even the smallest dose measurably reduces heart rate and blood pressure by lightening the heart's workload and reducing renin-driven narrowing of blood vessels. At this strength the effect on blood pressure is fairly mild, which is exactly why it is a safe place to begin, especially for older adults or people starting heart failure treatment. The dose is then raised gradually to reach full benefit.\n\nFrequently Asked Questions\n\n1. What is 1.25 mg of bisoprolol used for?\nMainly as a low starting dose when building up treatment for chronic heart failure, and for high blood pressure in people who are very sensitive to beta-blockers, such as older adults.\n\n2. What are the bad side effects of bisoprolol?\nThe more serious ones are a very slow pulse, fainting, worsening heart failure signs (swelling, breathlessness), severe allergy, and breathing trouble in people with lung conditions.\n\n3. What are the common side effects of bisoprolol fumarate 1.25 mg tablets?\nTiredness, dizziness, cold hands and feet, mild headache, and a slightly slower pulse.\n\n4. Is it better to take bisoprolol in the morning or at night?\nMorning is usually preferred so its effect fits daytime activity, though your doctor may suggest evenings in some cases.\n\n5. What is the cost of bisoprolol?\nPrice depends on strength, pack size, and brand. Use the “Check Price” option above for current BISOGARD 1.25 pricing from Steris Healthcare.\n\n6. Does 1.25 mg bisoprolol lower blood pressure?\nYes, though only modestly at this dose. The dose is often stepped up over time.\n\n7. Is bisoprolol safe for kidneys?\nGenerally yes for normal or mildly reduced kidney function. People with significant kidney impairment need dose adjustment and monitoring.\n\n8. Is bisoprolol a high-risk medication?\nIt is not a narrow therapeutic index drug, but it must never be stopped suddenly and should be used under medical supervision because of its direct effect on the heart.\n\n9. Can I take bisoprolol 1.25mg for the rest of my life?\nMany people with chronic heart failure or hypertension do take bisoprolol long term, but the dose usually rises as tolerated. Your doctor should review it regularly.\n\n10. What happens if I miss a dose of bisoprolol?\nTake it when you remember, unless the next dose is nearly due. In that case skip the missed one. Never take two together.\n\n11. Can bisoprolol 1.25mg cause weight gain?\nIt is not commonly reported at this dose. Fluid retention linked to heart failure itself should be reported to your doctor.\n\n12. Is bisoprolol safe for diabetic patients?\nIt can be used, with care, because beta-blockers may hide warning signs of low blood sugar such as a racing heartbeat.\n\n13. Can I stop taking bisoprolol suddenly if I feel fine?\nNo. Stopping abruptly can cause a rebound rise in heart rate, blood pressure, or chest pain. Reduce the dose gradually under medical guidance.\n\n14. Does bisoprolol interact with other blood pressure medicines?\nYes. Combining it with other drugs that lower heart rate or pressure (such as calcium channel blockers) can cause a very low pulse or pressure. Tell your doctor about all your medicines.\n\n15. Is BISOGARD 1.25 available without a prescription?\nNo. Bisoprolol is a Schedule H medicine in India and needs a valid prescription.\n\n16. How long does it take for bisoprolol 1.25mg to start working?\nSome effect on heart rate appears within hours, but the full benefit for blood pressure or heart failure symptoms builds over several weeks of regular use.\n\n17. Can pregnant women take bisoprolol?\nOnly if clearly necessary and prescribed by a doctor, as it may affect the baby's heart rate and growth.",
"price": 39.0,
"discountamount": 12.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2501,
"imageuri": "https://productimages.withfloats.com/actual/6abe4474c205678e0b16a23a.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6abe4474c205678e0b16a23a.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-01T11:30:57.88Z",
"updatedon": "2026-10-01T11:30:57.88Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//bisoprolol-1-25mg/2501",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Bisogard 1.25",
"category": "CARDIOLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}